Sartorius Stedim Biotech SA Stock Euronext Paris
Equities
STDM
FR0000053266
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | - |
Apr. 23 | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
Apr. 22 | Sartorius Stedim: in the red with brokerage comments | CF |
Sales 2024 * | 2.94B 3.15B | Sales 2025 * | 3.35B 3.58B | Capitalization | 20.27B 21.69B |
---|---|---|---|---|---|
Net income 2024 * | 343M 367M | Net income 2025 * | 459M 491M | EV / Sales 2024 * | 7.66 x |
Net Debt 2024 * | 2.27B 2.42B | Net Debt 2025 * | 2.15B 2.31B | EV / Sales 2025 * | 6.69 x |
P/E ratio 2024 * |
57.7
x | P/E ratio 2025 * |
41.7
x | Employees | - |
Yield 2024 * |
0.36% | Yield 2025 * |
0.53% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech SA
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 59 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
1st Jan change | Capi. | |
---|---|---|
-2.89% | 187B | |
-2.43% | 108B | |
-4.10% | 67.71B | |
+11.10% | 53.07B | |
+15.86% | 47.36B | |
+4.03% | 39.73B | |
+9.55% | 28.56B | |
+1.85% | 26.55B | |
+14.19% | 25.13B |
- Stock Market
- Equities
- DIM Stock
- STDM Stock